VivoSim Labs, Inc. (VIVS)
0.1561
+0.01
(+7.14%)
USD |
NASDAQ |
Oct 29, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
VivoSim Labs EPS Diluted (Quarterly) : -0.2554 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2554 |
| March 31, 2026 | -2.208 |
| December 31, 2025 | -1.032 |
| September 30, 2025 | -0.977 |
| June 30, 2025 | -1.136 |
| March 31, 2025 | 3.61 |
| December 31, 2024 | -2.291 |
| September 30, 2024 | -0.1416 |
| June 30, 2024 | -0.228 |
| March 31, 2024 | -0.3021 |
| December 31, 2023 | -0.3954 |
| September 30, 2023 | -0.4581 |
| June 30, 2023 | -0.4621 |
| March 31, 2023 | -0.8557 |
| December 31, 2022 | -0.3746 |
| September 30, 2022 | -0.3812 |
| June 30, 2022 | -0.3691 |
| March 31, 2022 | -0.2194 |
| December 31, 2021 | -0.402 |
| September 30, 2021 | -0.4026 |
| June 30, 2021 | -0.2912 |
| March 31, 2021 | -0.2994 |
| December 31, 2020 | -0.3661 |
| September 30, 2020 | -1.363 |
| June 30, 2020 | -0.424 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4172 |
| December 31, 2019 | -0.5166 |
| September 30, 2019 | -0.9656 |
| June 30, 2019 | -0.9968 |
| March 31, 2019 | -1.169 |
| December 31, 2018 | -1.101 |
| September 30, 2018 | -1.024 |
| June 30, 2018 | -1.40 |
| March 31, 2018 | -1.40 |
| December 31, 2017 | -1.40 |
| September 30, 2017 | -1.80 |
| June 30, 2017 | -24.00 |
| March 31, 2017 | -2.00 |
| December 31, 2016 | -1.80 |
| September 30, 2016 | -2.00 |
| June 30, 2016 | -1.80 |
| March 31, 2016 | -1.80 |
| December 31, 2015 | -2.20 |
| September 30, 2015 | -2.40 |
| June 30, 2015 | -2.00 |
| March 31, 2015 | -1.913 |
| December 31, 2014 | -1.80 |
| September 30, 2014 | -2.20 |
| June 30, 2014 | -1.60 |
| March 31, 2014 | -1.660 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.338M |
| Revenue (Quarterly) | 0.018M |
| Total Expenses (Quarterly) | 1.356M |
| Enterprise Value | -0.8886M |
| Gross Profit Margin (Quarterly) | -122.2% |
| Profit Margin (Quarterly) | -7.43K% |
| Earnings Yield | -2.86K% |
| Normalized Earnings Yield | -2984.43 |